Tomas Galván

Clinical relevance of the use of Dentoxol® for oral mucositis induced by radiotherapy: A phase II clinical trial

J. Oyarzún, N. Jara, C. Carvajal, 2022, World journal of clinical oncology.

Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial

R. Feinn, R. Lalla, P. Bettoli, 2020, Supportive Care in Cancer.